BioVie Inc. - Enterprise Value
BIVI
Price:
$1.76
Market Cap:
$13.27M
BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's developmental portfolio includes BIV201, a therapeutic agent that has successfully completed its Phase IIa clinical trial for addressing ascites resulting from chronic liver cirrhosis. Additionally, BioVie is advancing NE3107, which is currently undergoing a Phase III clinical trial for the management of mild to moderate Alzheimer's disease, and is also in a Phase I clinical trial for the treatment of Parkinson's disease. Further preclinical investigations are underway for NE3107, exploring its potent...[Read more]
Industry
Biotechnology
IPO Date
2020-09-18
Stock Exchange
NASDAQ
Ticker
BIVI
PE Ratio
[-0.47]
ROE
[-101.09%]
Current Ratio
[9.97]
Dividend Yield
[0%]
Enterprise Value
[470.38K]
Dividend History
The Enterprise Value as of June 2026 (TTM) for BioVie Inc. (BIVI) is 470.38K
According to BioVie Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 470.38K. This represents a change of -97.94% compared to the average of 22.86M of the last 4 quarters.
BioVie Inc. (BIVI) Historical Enterprise Value (quarterly & annually)
How has BIVI Enterprise Value performed in the past?
The mean historical Enterprise Value of BioVie Inc. over the last ten years is 52.93M. The current 470.38K Enterprise Value has changed -11.13% with respect to the historical average. Over the past ten years (40 quarters), BIVI's Enterprise Value was at its highest in in the March 2023 quarter at 2.84B. The Enterprise Value was at its lowest in in the September 2025 quarter at -14738297.50.
Average
52.93M
Median
29.31M
Minimum
-3528962.00
Maximum
205.72M
BioVie Inc. (BIVI) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of BioVie Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 400.27%
Maximum Annual Enterprise Value = 205.72M
Minimum Annual Increase = -424.55%
Minimum Annual Enterprise Value = -3528962.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -3528962.00 | -424.55% |
| 2024 | 1.09M | -99.19% |
| 2023 | 134.96M | 359.31% |
| 2022 | 29.38M | -85.72% |
| 2021 | 205.72M | 194.36% |
| 2020 | 69.89M | 139.10% |
| 2019 | 29.23M | 400.27% |
| 2018 | 5.84M | -77.33% |
| 2017 | 25.77M | -16.71% |
| 2016 | 30.94M | 45.27% |
BioVie Inc. (BIVI) Average Enterprise Value
How has BIVI Enterprise Value performed in the past?
The current Enterprise Value of BioVie Inc. (BIVI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
44.17M
5-year avg
73.53M
10-year avg
52.93M
BioVie Inc. (BIVI) Enterprise Value vs. Peers
How is BIVI’s Enterprise Value compared to its peers?
BioVie Inc.’s Enterprise Value is greater than Kazia Therapeutics Limited (-37291703.10), greater than PMGC Holdings Inc. (-3705156.00), less than Can-Fite BioPharma Ltd. (7.73B), greater than CERo Therapeutics Holdings, Inc. (-245885.00), greater than Theriva Biologics, Inc. (-1776656.00), greater than Galmed Pharmaceuticals Ltd. (-807047.00), less than Ocean Biomedical, Inc. (8.88M), greater than Artelo Biosciences, Inc. (-6577524.00), greater than InMed Pharmaceuticals Inc. (-2041995.00), greater than Lipella Pharmaceuticals Inc. (-1222021.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -37291703.10 | $22.45M | |
| -3705156.00 | $2.69M | |
| 7.73B | $1.60M | |
| -245885.00 | $13.26K | |
| -1776656.00 | $8.96M | |
| -807047.00 | $3.18M | |
| 8.88M | $118.64K | |
| -6577524.00 | $2.94M | |
| -2041995.00 | $2.70M | |
| -1222021.00 | $369.67K |
Build a custom stock screener for BioVie Inc. (BIVI) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioVie Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
BioVie Inc. (BIVI) and other stocks custom spreadsheet templates
The easiest way to analyze a company like BioVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BioVie Inc.'s Enterprise Value?
What is the highest Enterprise Value for BioVie Inc. (BIVI)?
What is the 3-year average Enterprise Value for BioVie Inc. (BIVI)?
What is the 5-year average Enterprise Value for BioVie Inc. (BIVI)?
How does the current Enterprise Value for BioVie Inc. (BIVI) compare to its historical average?